Speeches and Presentations

Research!America leadership and board members often speak out on the need to advocate for more federal funding for health research.

Research!America President and CEO Mary Woolley spoke at a weekly Master Seminar on "A Career in Science Policy at a Time of Change and Opportunity" at Rice University for its Professional Science Master's Program.

Mary Woolley presented Advocacy Leadership in Unsettled Times at the World Stem Cell Summit in Pasadena, CA. Research!America was also honored with a Genetics Policy Institute Stem Cell Action Award.

Mary Woolley discussed public opinion regarding federal support for stem cell research in a presentation at the World Stem Cell Summit in Detroit in 2010.

Mary Woolley presented Medical Research is a Priority in Montana and Nationally at the McLaughlin Research Institute's National Development Council meeting in Great Falls, MT. 

Mary Woolley presented World-Class Advocacy for World-Class Science: A Call to Action at the 2011 General Meeting of the American Society for Microbiology.

Mary Woolley presented poll findings from a Maryland state poll at the forum, "Let Me Be Clear: Science Journalism in the Age of the Genome and Twitter," in Washington, DC. 

The Honorable John Edward Porter, Research!America's chair, made remarks during a panel session at the American Association for Cancer Research's annual meeting.

Members of Research!America's Executive Committee made presentations at our 2011 Annual Meeting of Members: Part 1Part 2

Mary Woolley presented "Economic Returns of Life Science Research: Importance to Policy Makers" at the National Academies Board on Life Sciences in San Francisco. 

Mary Woolley presented "A Few How–To‘s on Garnering Congressional Support for Advocacy " at the National Center for Science Education


Media Contacts

Robert Shalett
Director of Communications 

Without continued support for health research, many of the most promising young scientists, their ideas and a myriad of potentially life-changing scientific breakthroughs will vanish into oblivion.
Paul Marinec, PhD; University of California San Francisco